The independent source for health policy research, polling, and news.
6,021-6,040 of 112,937 results
An analysis of the company's late-stage trial data flags a concern that the efficacy of Moderna's RSV shot may decline more quickly than those of Pfizer or GSK. In a different study, data from Spain shows that nirsevimab is helping to avoid hospitalizations in infants.
Today's early morning highlights from the major news organizations.
Editorial writers discuss concussion testing, CTE in football, President Joe Biden's age, cancer research, and more.
The new higher-dose nasal spray did not save more lives than the regular dose, and it drove up side effects. Separately, reports say opioid overdoses are rising among teens, but inpatient care remains rare. Also in the news: CDC data show how teens use drugs to combat stress.
Meanwhile, the Covered California sign-up window is set to close at midnight tonight. In other health news from across the U.S., Virginia Democrats push to expand state-funded health insurance to undocumented children; a bill would allow Florida hospital districts to convert to nonprofits; and more.
In a report in NEJM, researchers detailed how the fungus attacked the base of the brains of patients exposed at medical clinics in Mexico. Twelve people died in the outbreak last year.
Native Americans are less likely than other racial groups to earn a place on the liver transplant list, according to an analysis of transplant data by the Markup and The Washington Post. Separately, scrutiny of rising private equity roles in home health care; a cyberattack at Lurie Children's Hospital; a lawsuit for nurse meal breaks in San Francisco; and more.
Though phenylephrine has been found ineffective as a decongestant, if the FDA pulled drugs from pharmacy shelves, it would disrupt a wave of supply chain problems, experts warn. In other news, CARB-X is funding development of a rapid test for gonorrhea.
The end of this effort allows a competing, more sweeping constitutional amendment to make November's ballot, AP notes. Meanwhile, USA Today reports that cities are being targeted with local abortion bans in the aftermath of the end of Roe v. Wade.
The Washington Post reports on a "cascade" of gun-control bills passing through the Virginia General Assembly, although they face an uncertain reception with the Republican governor. Separately, the Biden administration asked the Supreme Court to overturn a rule barring "ghost gun" limits.
The Senate Committee on Health, Education, Labor and Pensions, led by Sen. Bernie Sanders, held a hearing Thursday on the cost of prescriptions drugs. The CEOs for Bristol Myers Squibb, Johnson & Johnson, and Merck faced questions on pricing practices and why medicines cost more in the U.S. than other countries.
"My memory’s fine," President Joe Biden said at a press conference Thursday night, strongly defending his age and cognitive abilities in response to a special counsel report on the president's handling of classified documents. The document cited several examples when Biden couldn't recall key dates.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News finds longer stories for you to enjoy. This week's selections include stories on mental health, "magic" mushrooms, nursing homes, surrogacy, and more.
Each week, KFF Health News compiles a selection of recently released health policy studies and briefs.
Editorial writers tackle counterfeit drugs, parental vaccine hesitancy, HIV, and more.
Stateline reports on public health experts' warnings that awareness of rising TB is lagging and that state and local health services lack resources to keep up with prevention and control. Meanwhile, the CDC is checking protocols on a cruise ship where more than 100 people had gastrointestinal illnesses.
Ohio's proposed restrictions would have been the toughest on transition-related care for adults in the country, trans rights advocates said. Separately, a survey shows that transgender Americans have been experiencing economic and health disparities for years.
The facility in Bloomington, Indiana, belonged to contract drugmaker Catalent. FDA inspectors found issues including a "pest" on the manufacturing line. Novo is buying Catalent to boost Wegovy production. Also: A report says FDA oversight of foreign firms making U.S. market drugs is weak.
The Mayo Clinic Health System's New Prague hospital is the latest facility in the state to stop delivering babies. Minnesota Public Radio reports on how midwives are filling the void in birthing services as hospitals move deliveries to larger, centralized hospitals.
© 2026 KFF